Caliper Reports Increased Q4 Revenues, But Dips Back into Red | GenomeWeb

NEW YORK, Feb 1 – Ending a quarter marked mainly by its settlement of its long patent infringement lawsuit with Aurora Biosciences, Caliper technologies reported Thursday that its revenues for the fourth quarter jumped 55 percent from the year-ago quarter, based on a new deal with Agilent technologies, while operating expenses also jumped to account for increased R&D and intellectual property expenditures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.